TN2015000161A1 - Methylglyoxal as a marker of cancer - Google Patents

Methylglyoxal as a marker of cancer

Info

Publication number
TN2015000161A1
TN2015000161A1 TNP2015000161A TN2015000161A TN2015000161A1 TN 2015000161 A1 TN2015000161 A1 TN 2015000161A1 TN P2015000161 A TNP2015000161 A TN P2015000161A TN 2015000161 A TN2015000161 A TN 2015000161A TN 2015000161 A1 TN2015000161 A1 TN 2015000161A1
Authority
TN
Tunisia
Prior art keywords
cancer
methylglyoxal
early detection
cells
marker
Prior art date
Application number
TNP2015000161A
Other languages
English (en)
Inventor
Dominique Belpomme
Philippe Irigaray
Original Assignee
Ass Pour La Rech Therapeutique Anti-Cancereuse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ass Pour La Rech Therapeutique Anti-Cancereuse filed Critical Ass Pour La Rech Therapeutique Anti-Cancereuse
Publication of TN2015000161A1 publication Critical patent/TN2015000161A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
TNP2015000161A 2012-10-25 2015-04-24 Methylglyoxal as a marker of cancer TN2015000161A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2012/071163 WO2014063743A1 (fr) 2012-10-25 2012-10-25 Méthylglyoxal en tant que marqueur du cancer
PCT/EP2013/072459 WO2014064283A1 (fr) 2012-10-25 2013-10-25 Méthylglyoxal en tant que marqueur du cancer

Publications (1)

Publication Number Publication Date
TN2015000161A1 true TN2015000161A1 (en) 2016-10-03

Family

ID=47074733

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2015000161A TN2015000161A1 (en) 2012-10-25 2015-04-24 Methylglyoxal as a marker of cancer

Country Status (11)

Country Link
US (1) US20150301056A1 (fr)
JP (1) JP6543193B2 (fr)
CN (1) CN104854458B (fr)
CA (1) CA2889110A1 (fr)
DK (1) DK2912465T3 (fr)
ES (1) ES2656896T3 (fr)
MA (1) MA38042B2 (fr)
PT (1) PT2912465T (fr)
RU (1) RU2666255C2 (fr)
TN (1) TN2015000161A1 (fr)
WO (2) WO2014063743A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106769349B (zh) * 2017-01-06 2020-01-21 上海君联医疗设备有限公司 血液中异常糖基化蛋白细胞的检测方法
CN108426996B (zh) * 2017-02-15 2020-09-15 江苏美正生物科技有限公司 一种3-甲基喹噁啉-2-羧酸残留的快速检测试剂盒及其制备方法和应用
GB2566681B (en) * 2017-09-14 2021-07-28 Ip2Ipo Innovations Ltd Biomarker
CN108061802A (zh) * 2017-12-08 2018-05-22 武汉科技大学 一种通过血液检测评定乳腺癌的方法
US20220050109A1 (en) * 2018-11-18 2022-02-17 National University Of Singapore Method of detecting cancer and/or tuberculosis
CN110604823B (zh) * 2019-10-21 2020-10-20 兰州大学 一种快速筛选抗糖化和/或抗衰老物质的方法
CN113376199A (zh) * 2021-05-12 2021-09-10 兰立生物科技(苏州)有限公司 一种用于癌症检测的生化分析检测系统
CN114496306B (zh) * 2022-01-28 2022-12-20 北京大学口腔医学院 基于机器学习的预后生存阶段预测方法和系统
US20220206017A1 (en) * 2022-03-18 2022-06-30 Joel Steven Goldberg Aerobic glycolysis and hypermetabolic states

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2007073005A1 (ja) * 2005-12-22 2009-06-04 学校法人慶應義塾 メチル基転移反応調節物質
US8026049B2 (en) * 2007-03-23 2011-09-27 Wisconsin Alumni Research Foundation Noninvasive measurement and identification of biomarkers in disease state
JP4836926B2 (ja) * 2007-11-12 2011-12-14 株式会社日本トリム 糖分解代謝物の測定方法
JP5787339B2 (ja) * 2009-12-28 2015-09-30 学校法人福岡大学 糖尿病前症の検査方法
CA2828119A1 (fr) * 2011-02-24 2012-08-30 Vermillion, Inc. Panel de marqueurs biologiques, procedes de diagnostic et necessaires d'essais pour le cancer de l'ovaire

Also Published As

Publication number Publication date
JP2016500821A (ja) 2016-01-14
WO2014063743A1 (fr) 2014-05-01
RU2015119512A (ru) 2016-12-20
JP6543193B2 (ja) 2019-07-10
DK2912465T3 (en) 2018-01-15
CN104854458A (zh) 2015-08-19
ES2656896T3 (es) 2018-02-28
CN104854458B (zh) 2018-02-09
RU2666255C2 (ru) 2018-09-06
PT2912465T (pt) 2018-01-25
CA2889110A1 (fr) 2014-05-01
US20150301056A1 (en) 2015-10-22
WO2014064283A1 (fr) 2014-05-01
MA38042B2 (fr) 2019-11-29
MA38042A2 (fr) 2017-02-28
MA38042A3 (fr) 2018-03-30

Similar Documents

Publication Publication Date Title
TN2015000161A1 (en) Methylglyoxal as a marker of cancer
WO2006091412A3 (fr) Proteine adamts-7 utilisee en tant que biomarqueur pour des cancers d'origine epitheliale
IN2014MN02060A (fr)
MX361731B (es) Método para diagnosticar cáncer y kit de diagnóstico usando medición de actividad de células nk.
MX343327B (es) Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.
WO2009090553A3 (fr) Compositions et procédés de détection de peptides post-arrêts
BR112015003715A8 (pt) análise de raman, de infravermelho, ou de raman-infravermelho da estrutura de proteína de plasma de sangue periférico e sua relação para desenvolvimento cognitivo no mal de alzheimer
MX2010006484A (es) Composiciones y metodos para detectar anticuerpos de infidelidad de transcripcion (tiab).
BRPI1007321A2 (pt) métodos para medir e/ou quantificar a presença e/ou quantidade de her-3 ou her-3 em um complexo em uma amostra de um paciente, e para determinar se um indivíduo com um câncer é provável de responder ao tratamento com uma terapia alvejada, e, anticorpo.
MX361944B (es) Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales.
WO2013190075A3 (fr) Biomarqueurs spécifiques pour un carcinome hépatocellulaire (hcc)
BR112013010015A2 (pt) aparelho e método para detecção não invasiva de doenças que afetam as propriedades estruturais em tecidos biológicos
WO2011145807A3 (fr) Dispositif pour l'examen de la fonction nerveuse
WO2014036495A3 (fr) Dosages diagnostiques et nécessaires de détection du récepteur-1 aux folates
BR112012031389A2 (pt) método para prever os resultados clínicos para pacientes com melanoma usando células de melanoma circulantes no sangue
RU2013105265A (ru) Способ диагностики рака поджелудочной железы
MX2018001697A (es) Método para la cuantificación de los miembros del filogrupo i y/o del filogrupo ii de faecalibacterium prausnitzii y el uso de los mismos como biomarcadores.
EA201590686A1 (ru) Тест на митохондриальную токсичность
EP2573192A4 (fr) Procédé et kit pour diagnostiquer une maladie associée à l'aim
JP2016500821A5 (fr)
EP2524219A4 (fr) Procédés de détection et d'analyse de biomolécules et de complexes de biomolécules (bmc) et leur utilisation pour la recherche et le diagnostic médical
WO2010136163A8 (fr) Sécernine-1, en tant que marqueur du cancer
GB2515713A (en) Methods, packaging and apparatus for collection of biological samples
WO2014052685A3 (fr) Dispositifs et méthodes d'analyse monocellulaire
GB201102693D0 (en) Method for identifying neonates at risk for necrotizing enterocolitis